Last reviewed · How we verify
NCT05095428: PARTS2
Program for Alleviating and Resolving Trauma and Stress 2
NA trial testing PARTS Program in Post-traumatic Stress Disorder in 82 participants. Completed in 8 November 2023.
12 September 2023
Quick facts
| Lead sponsor | Cambridge Health Alliance |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 82 |
| Start date | 28 April 2022 |
| Primary completion | 12 September 2023 |
| Estimated completion | 8 November 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- PARTS Program
- NBSR-T Program
Conditions studied
- Post-traumatic Stress Disorder — all drugs for Post-traumatic Stress Disorder →
Sponsor
Cambridge Health Alliance — full company profile →
Who can join
Adults 18 to 75, any sex, with Post-traumatic Stress Disorder. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This pilot RCT will test the preliminary efficacy of an intensive group model of Internal Family Systems (IFS) called the Program for Alleviating and Resolving Trauma and Stress (PARTS) compared with a Nature-Based Stress Reduction for Trauma Survivors (NBSR-T) attention placebo control group at reducing PTSD symptom severity measured by Clinician-Administered PTSD Scale (CAPS-5). In addition, the effects of the interventions on self-reported PTSD symptoms, disassociation, and disturbances of self-organization (DSO), as well as mechanisms of emotion regulation, decentering and self-compassion will be secondary outcomes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05095428
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of PARTS Program
Trials testing the same drug.
- NCT04713501 — Program for Alleviating and Resolving Trauma and Stress 1 · NA · completed
Other recruiting trials for Post-traumatic Stress Disorder
Currently open trials in the same condition.
- NCT06943404 — BXCL501 After Stress to Increase Recovery Success · Phase 2 · recruiting
- NCT06477796 — Improving Sleep in Veterans With the Polytrauma Clinical Triad · NA · recruiting
- NCT06538246 — Adaptive Coping Skills Training to Improve Psychological Distress Among Cardiorespiratory Failure Survivors · NA · recruiting
- NCT06592677 — Early Support After Exposure to Trauma · NA · recruiting
- NCT05927324 — Clinician-Assisted Videofeedback Exposure-Approach Therapy (CAVEAT) Trial · NA · recruiting
Other Cambridge Health Alliance trials
Trials by the same sponsor.
- NCT06419595 — Screening and Support for Youth (SASY) · NA · not yet recruiting
- NCT07513220 — The Effectiveness and Acceptability of Formal Versus Informal Mindful Self-Compassion for Adolescents · NA · not yet recruiting
- NCT06988462 — Pilot Study of "Bottarga" Supplementation: A Little-known, Sustainable "Blue" Food · NA · recruiting
- NCT06564948 — Treatment for Individuals Interacting with the Criminal Justice System · NA · recruiting
- NCT06765122 — Program for Alleviating and Reducing Trauma and Stress for Intimate Partner Violence · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05095428 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cambridge Health Alliance
- Last refreshed: 3 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05095428.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing